EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis

Sophy T F Shih, Qinglu Cheng, Joanne Carson, Heather Valerio, Yumi Sheehan, Richard T Gray, Evan B Cunningham, Jisoo A Kwon, Andrew R Lloyd, Gregory J Dore, Virginia Wiseman, Jason Grebely

The Lancet Regional Health - Western Pacific · 2023-07 · 36 · 100750

DOI: 10.1016/j.lanwpc.2023.100750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Lancet Regional Health - Western Pacific, 2023-07. Verfasst von Sophy T F Shih und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, University of New South Wales, Level 6, Wallace Wurth Building, Sydney 2052, Australia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Government, Department of Health and Ageing, Australian Government, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Timely diagnosis and treatment of hepatitis C virus (HCV) is critical to achieve elimination goals. This study evaluated the cost-effectiveness of point-of-care testing strategies for HCV compared to laboratory-based testing in standard-of-care.

Methods

Cost-effectiveness analyses were undertaken from the perspective of Australian Governments as funders by modelling point-of-care testing strategies compared to standard-of-care in needle and syringe programs, drug treatment clinics, and prisons. Point-of-care testing strategies included immediate point-of-care HCV RNA testing and combined point-of-care HCV antibody and reflex RNA testing for HCV antibody positive people (with and without consideration of previous treatment). Sensitivity analyses were performed to investigate the cost per treatment initiation with different testing strategies at different HCV antibody prevalence levels.

Findings

The average costs per HCV treatment initiation by point-of-care testing, from A$890 to A$1406, were up to 35% lower compared to standard-of-care ranging from A$1248 to A$1632 depending on settings. The average costs per treatment initiation by point-of-care testing for three settings ranged from A$1080 to A$1406 for RNA, A$960-A$1310 for combined antibody/RNA without treatment history consideration, and A$890-A$1189 for combined antibody/RNA with treatment history consideration. When HCV antibody prevalence was

Schlagwörter

Stichwörter der Autor:innen

Antibody testingHCVHealth economicsModellingRNA testing

Autor:innen und Institutionen

  • The Kirby Institute, University of New South Wales, Level 6, Wallace Wurth Building, Sydney 2052, Australia.
  • Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.

Förderung

  • Australian Government
  • Department of Health and Ageing, Australian Government
  • National Health and Medical Research Council

Zitieren

APA

Shih, S. T. F., Cheng, Q., Carson, J., Valerio, H., Sheehan, Y., Gray, R. T., Cunningham, E. B., Kwon, J. A., Lloyd, A. R., Dore, G. J., Wiseman, V., & Grebely, J. (2023). Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis. The Lancet Regional Health - Western Pacific, 36, 100750. https://doi.org/10.1016/j.lanwpc.2023.100750

Vancouver

Shih STF, Cheng Q, Carson J, Valerio H, Sheehan Y, Gray RT, et al. Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis. The Lancet Regional Health - Western Pacific. 2023;36:100750. doi:10.1016/j.lanwpc.2023.100750

BibTeX
@article{Shih2023,
  author = {Shih, Sophy T F and Cheng, Qinglu and Carson, Joanne and Valerio, Heather and Sheehan, Yumi and Gray, Richard T and Cunningham, Evan B and Kwon, Jisoo A and Lloyd, Andrew R and Dore, Gregory J and Wiseman, Virginia and Grebely, Jason},
  title = {Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis},
  journal = {The Lancet Regional Health - Western Pacific},
  year = {2023},
  volume = {36},
  pages = {100750},
  doi = {10.1016/j.lanwpc.2023.100750}
}
Kostenlos starten →